Zepp Health (ZEPP) Research & Development (2016 - 2025)
Zepp Health has reported Research & Development over the past 10 years, most recently at -$11.0 million for Q4 2025.
- For Q4 2025, Research & Development rose 0.71% year-over-year to -$11.0 million; the TTM value through Dec 2025 reached -$45.3 million, up 1.82%, while the annual FY2025 figure was $45.3 million, 1.82% down from the prior year.
- Research & Development for Q4 2025 was -$11.0 million at Zepp Health, down from -$10.8 million in the prior quarter.
- Over five years, Research & Development peaked at $23.2 million in Q1 2021 and troughed at -$24.8 million in Q2 2021.
- A 5-year average of -$12.6 million and a median of -$12.6 million in 2023 define the central range for Research & Development.
- Biggest five-year swings in Research & Development: crashed 249.66% in 2021 and later skyrocketed 42.12% in 2023.
- Year by year, Research & Development stood at -$14.7 million in 2021, then decreased by 12.65% to -$16.6 million in 2022, then skyrocketed by 32.9% to -$11.1 million in 2023, then increased by 0.57% to -$11.1 million in 2024, then increased by 0.71% to -$11.0 million in 2025.
- Business Quant data shows Research & Development for ZEPP at -$11.0 million in Q4 2025, -$10.8 million in Q3 2025, and -$11.2 million in Q2 2025.